AI and nudge tactics aim to catch hidden high cholesterol

NCT ID NCT05746247

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study uses a machine-learning tool to scan electronic health records and flag patients likely to have familial hypercholesterolemia (FH), a genetic condition causing very high cholesterol. Researchers then test a simple referral system that automatically schedules a visit with a lipid specialist unless the doctor opts out. The goal is to see if this approach leads to more diagnoses and better cholesterol management in 750 patients at Penn Medicine.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Centralized referral mechanism (default/opt-out referrals) and telehealth appointments with a lipid specialist
What this could lead to
If successful, this approach could help many more people with familial hypercholesterolemia get diagnosed and treated earlier, reducing their risk of heart disease.
What could go wrong
This is an early-stage implementation study, not a treatment trial. It tests a referral process, not a new drug or cure, so the direct health impact depends on follow-up care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FAMILIAL HYPERCHOLESTEROLEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

familial hypercholesterolemia Hyperlipoproteinemia Type II

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Pennsylvania Health System

    Philadelphia, Pennsylvania, 19146, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.